Table 1.

Serotonin tissue content (picograms per microliter) and turnover (5-HIAA/5-HT)

Brain regionWT-salineCREBαΔ-salineWT-PCPACREBαΔ-PCPA
LevelsTurnoverLevelsTurnoverLevelsTurnoverLevelsTurnover
Amygdala367 ± 220.52 ± 0.03338 ± 240.53 ± 0.0362 ± 40.24 ± 0.0157 ± 60.25 ± 0.02
Frontal cortex223 ± 60.53 ± 0.02196 ± 110.52 ± 0.0254 ± 210.33 ± 0.1334 ± 80.19 ± 0.03
Hippocampus653 ± 591.07 ± 0.05690 ± 591.14 ± 0.0882 ± 70.36 ± 0.0364 ± 90.32 ± 0.05
Nucleus accumbens195 ± 110.52 ± 0.06198 ± 350.42 ± 0.0341 ± 70.23 ± 0.0437 ± 90.18 ± 0.04
Brainstem457 ± 361.04 ± 0.09440 ± 381.02 ± 0.07128 ± 220.92 ± 0.05124 ± 160.69 ± 0.07
  • Mice (n = 8–9 per group) were killed 18 h after the last injection of PCPA. Brains were microdissected and HPLC coupled with EC was used to assay the filtered supernatant for serotonin content. Baseline serotonin levels, turnover, and depletion in CREBαΔ mutant mice did not differ from that of WT mice throughout the amygdala, cortex, hippocampus, nucleus accumbens, and raphe.